Improved interpretation and clinical validation of substitutions in HIV-1 protease predicting the virological response to darunavir/ritonavir

被引：0
|
作者：
De Luca, A. [1 ]
Di Giambenedetto, S. [1 ]
Marando, F. [2 ]
Maserati, R. [3 ]
Gianotti, N. [4 ]
Narciso, P. [5 ]
Antinori, A. [5 ]
Di Perri, G. [6 ]
Baldanti, F. [3 ]
Zazzi, M. [7 ]
Perno, C. F. [2 ]
Santoro, M. M. [2 ]
机构：
[1] Catholic Univ, Rome, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] Policlin San Matteo IRCCS, Pavia, Italy
[4] Hosp San Raffaele, I-20132 Milan, Italy
[5] IRCCS, Natl Inst Infect Dis L Spallanzani, Rome, Italy
[6] Univ Turin, Turin, Italy
[7] Univ Siena, I-53100 Siena, Italy
来源：
ANTIVIRAL THERAPY | 2008年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A104 / A104
页数：1
相关论文
共 50 条
  • [31] Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat
    Marin, Ruxandra-Cristina
    Streinu-Cercel, Adrian
    Moleriu, Lavinia Cristina
    Bungau, Simona Gabriela
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [32] The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors
    Fox, Zoe V.
    Geretti, Anna Maria
    Kjaer, Jesper
    Dragsted, Ulrik Bak
    Phillips, Andrew N.
    Gerstoft, Jan
    Staszewski, Schlomo
    Clotet, Bonaventura
    von Wyl, Viktor
    Lundgren, Jens D.
    AIDS, 2007, 21 (15) : 2033 - 2042
  • [33] Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir
    Liu, Fengling
    Kovalevsky, Andrey Y.
    Tie, Yunfeng
    Ghosh, Arun K.
    Harrison, Robert W.
    Weber, Irene T.
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 381 (01) : 102 - 115
  • [34] Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
    Frentz, Dineke
    Boucher, Charles A. B.
    Assel, Matthias
    De Luca, Andrea
    Fabbiani, Massimiliano
    Incardona, Francesca
    Libin, Pieter
    Manca, Nino
    Mueller, Viktor
    Nuallain, Breanndan O.
    Paredes, Roger
    Prosperi, Mattia
    Quiros-Roldan, Eugenia
    Ruiz, Lidia
    Sloot, Peter M. A.
    Torti, Carlo
    Vandamme, Anne-Mieke
    Van Laethem, Kristel
    Zazzi, Maurizio
    van de Vijver, David A. M. C.
    PLOS ONE, 2010, 5 (07):
  • [35] Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease
    Lockbaum, Gordon J.
    Leidner, Florian
    Rusere, Linah N.
    Henes, Mina
    Kosovrasti, Klajdi
    Nachum, Gily S.
    Nalivaika, Ellen A.
    Ali, Akbar
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    ACS INFECTIOUS DISEASES, 2019, 5 (02): : 316 - 325
  • [36] FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
    Hathaichanok Chuntakaruk
    Kowit Hengphasatporn
    Yasuteru Shigeta
    Chanat Aonbangkhen
    Vannajan Sanghiran Lee
    Tanatorn Khotavivattana
    Thanyada Rungrotmongkol
    Supot Hannongbua
    Scientific Reports, 14
  • [37] Safety, pharmacokinetics, and antiviral activity of ritonavir, an inhibitor of HIV-1 protease
    Danner, SA
    Carr, A
    Leonard, JM
    Lehman, LM
    Gudiol, F
    Gonzales, J
    Raventos, A
    Rubio, R
    Bouza, E
    Pintado, V
    Aguado, AG
    Delgado, R
    Borleffs, JCC
    Hsu, A
    Valdes, JM
    Boucher, CAB
    Cooper, DA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 75 - 75
  • [38] Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
    Marcelin, A. G.
    Lambert-Niclot, S.
    Canestri, A.
    Soulie, C.
    Wirden, M.
    Tubiana, R.
    Cheret, A.
    Katlama, C.
    Flandre, P.
    Calvez, V.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A51 - A51
  • [39] Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV
    Ghosh, Arun K.
    Dawson, Zachary L.
    Mitsuya, Hiroaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (24) : 7576 - 7580
  • [40] FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
    Chuntakaruk, Hathaichanok
    Hengphasatporn, Kowit
    Shigeta, Yasuteru
    Aonbangkhen, Chanat
    Lee, Vannajan Sanghiran
    Khotavivattana, Tanatorn
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345